KYMR ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/5/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-0.62
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)65.00M
Kymera Therapeutics Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Kymera Therapeutics Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Kymera Therapeutics Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Kymera Therapeutics Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Kymera Therapeutics Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
KYMR ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
KYMR FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-3.69-23.53%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)39.21M-16.70%
Kymera Therapeutics Inc(KYMR) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | -0.62/-0.71 | 65.00M/31.16M | 12.56% | 108.57% |
| 4/30/2026 | 03/2026 | -0.71/-0.88 | 34.37M/8.61M | 19.49% | 298.95% |
| 2/26/2026 | 12/2025 | -0.97/-0.80 | 2.87M/15.05M | -21.37% | -80.93% |
| 11/4/2025 | 09/2025 | -0.94/-0.80 | 2.76M/18.95M | -17.08% | -85.42% |
| 8/11/2025 | 06/2025 | -0.95/-0.81 | 11.48M/23.39M | -17.57% | -50.93% |
| 5/9/2025 | 03/2025 | -0.82/-0.92 | 22.10M/10.15M | 10.69% | 117.63% |
| 2/27/2025 | 12/2024 | -0.88/-0.77 | 7.39M/11.82M | -13.93% | -37.45% |
| 10/31/2024 | 09/2024 | -0.82/-0.84 | 3.74M/10.36M | 2.13% | -63.89% |